Home Page – V1

HEALTH EQUITY HEALTH EQUITY For America’s pharmacy benefit companies, our mission is simple: increase affordable access to prescription drugs for everyone. We believe care should be patient-focused, equitable, and affordable. LEARN MORE UNLOCKING AN AFFORDABLE FUTURE UNLOCKING AN AFFORDABLE FUTURE

Read More »

PCMA Policy Forum 2023

Dismay over the price of prescription drugs continues to pervade politics and popular culture. Last year, the Inflation Reduction Act, with its Medicare Part D redesign and drug negotiation provisions, shifted the dynamics of the prescription drug market and policymakers
Read More »

Become a Member

Ten reasons why joining PCMA is vital to your company’s strategic interests: 1. SET INDUSTRY DIRECTION PCMA’s members shape the industry’s direction and positions on a broad range of public policy issues that affect your business. No other trade group
Read More »

PBMs Support Patient Access to Biosimilars and Reference Biologics

PBMs Support and Encourage Biosimilar Competition Increased biosimilar competition drives down prescription drug costs  Having multiple biosimilar and reference biologic competitor products with equivalent patient benefits on the market allows pharmacy benefit companies, PBMs, to push manufacturers to compete on

Read More »

Katie Payne

Katie Payne Senior Vice President, Public Affairs and Head of Advocacy Katie (Carr) Payne is Senior Vice President, Public Affairs and Head of Advocacy at PCMA. In this role, Katie is responsible for leading PCMA’s communications function and oversees the association’s

Read More »

Equitable Health Care System – OLD

Health Equity Working together for a more equitable health care system. For America’s PBMs, our mission is simple: increase affordable access to prescription drugs for everyone. We believe care should be patient-focused, equitable, and affordable. We commit to industry action

Read More »

About

About PCMA The Pharmaceutical Care Management Association (PCMA) is the national association representing America’s pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 275 million Americans who have health insurance from a variety of sponsors including: commercial

Read More »

New Data: Rebates are Unrelated to Drugmakers’ Pricing Strategies

(Washington, D.C.) — As the Administration considers modifying price concessions for prescription drugs in Medicare and federal programs, the Pharmaceutical Care Management Association (PCMA) is releasing new data, “Reconsidering Drug Prices, Rebates, and PBMs,” showing drug manufacturers alone set prices –

Read More »

PCMA Applauds House Passage of Bill Curbing Opioid Epidemic

(Washington, D.C.) — Today, the U.S. House of Representatives passed a legislative package, SUPPORT for Patients and Communities Act (H.R. 6), which requires electronic prescribing (e-prescribing) of controlled substances in Medicare. This is an important step in the fight against America’s

Read More »

Policies To Reduce Prescription Drug Costs in 2021

The Pharmaceutical Care Management Association (PCMA) is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health coverage from a variety of sponsors. PCMA continues to lead
Read More »